Halozyme Therapeutics Inc (HALO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HALO? Forum Prognose

Finanzdaten der Halozyme Therapeutics Inc-Aktie (HALO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	27.52% 451.77	354.26	325.72	264.86	298.01
Cost Of Revenue	42.59% 78.77	55.24	46.36	48.40	42.05
Gross Profit	24.74% 373.00	299.02	279.36	216.46	255.95
Operating Expenses	474.45% 465.89	81.10	76.92	74.92	80.45
Benefits Costs and Expenses	308.42% 552.62	135.31	120.78	121.03	119.79
Costs And Expenses	299.48% 544.66	136.34	123.28	123.33	122.51
Operating Income/Loss	142.63% -92.89	217.92	202.44	141.53	175.50
Income/Loss From Continuing Operations Before Tax	146.06% -100.85	218.96	204.94	143.83	178.21
Income Tax Expense/Benefit	6.84% 40.74	43.73	39.78	25.73	41.20
Income/Loss From Continuing Operations After Tax	180.81% -141.59	175.22	165.16	118.09	137.01
Net Income/Loss	180.81% -141.59	175.22	165.16	118.09	137.01
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.62% -0.73	117.22	121.34	123.22	-0.142
Diluted Average Shares	100.45% -0.545	122.33	124.16	126.64	-0.102
Basic Earnings Per Share	177.85% -1.16	1.49	1.36	0.96	1.08
Diluted Earnings Per Share	178.32% -1.12	1.43	1.33	0.93	1.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%